BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19851328)

  • 1. Preclinical cardiovascular abnormalities in patients in early stages of renal disease without nephrotic syndrome.
    Esposito P; Palmieri V; Migliaresi P; Pezzullo S; Martino S; Balletta MM
    Hypertens Res; 2009 Dec; 32(12):1155-6. PubMed ID: 19851328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study].
    de Francisco AL; De la Cruz JJ; Cases A; de la Figuera M; Egocheaga MI; Górriz JI; Llisterri JI; Marín R; Martínez Castelao A
    Nefrologia; 2007; 27(3):300-12. PubMed ID: 17725449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic renal insufficiency and cardiovascular disease].
    Charriere S; Rognant N; Chiche F; Cremer A; Deray G; Priou M
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of chronic kidney disease in Italy: the CARHES study].
    De Nicola L; Dal Canton A;
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):106S-108S. PubMed ID: 20879494
    [No Abstract]   [Full Text] [Related]  

  • 5. Can changing antihypertensive administration time alone reduce the risk for CVD in nondipper patients with CKD?
    Fukuda M
    Am J Kidney Dis; 2008 Jul; 52(1):193; author reply 193-4. PubMed ID: 18589219
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in chronic kidney disease.
    Saran AM; DuBose TD
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency.
    Briganti EM; Kerr PG; Shaw JE; Zimmet PZ; Atkins RC
    Nephrology (Carlton); 2005 Feb; 10(1):40-7. PubMed ID: 15705181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early detection of chronic kidney disease: epidemiological data on renal dysfunction].
    Cirillo M; Del Giudice L; Bilancio G; Franzese MD; Chiricone D; De Santo NG
    G Ital Nefrol; 2008; 25(6):690-3. PubMed ID: 19048569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention.
    Bachorzewska-Gajewska H; Malyszko J; Malyszko JS; Musial W; Dobrzycki S
    Nephrology (Carlton); 2006 Dec; 11(6):549-54. PubMed ID: 17199796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in patients hospitalized with nephrotic syndrome.
    Kayali F; Najjar R; Aswad F; Matta F; Stein PD
    Am J Med; 2008 Mar; 121(3):226-30. PubMed ID: 18328307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotic syndrome and chronic renal insufficiency associated with essential cryofibrinogenemia.
    Singh A; Gaber LW
    Nephrol Dial Transplant; 2007 Jun; 22(6):1772-5. PubMed ID: 17395660
    [No Abstract]   [Full Text] [Related]  

  • 13. The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small, unilateral renal masses.
    Lucas SM; Nuss G; Stern J; Lotan Y; Sagalowsky AI; Cadeddu JA; Raj GV
    Cancer; 2008 Nov; 113(10):2681-6. PubMed ID: 18853420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors for the development and progression of cardiorenal complications in women].
    Chicherina EN; Padyganova AV
    Ter Arkh; 2013; 85(6):85-9. PubMed ID: 23866604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides and renal insufficiency: clinical significance and role of renal clearance.
    Freda BJ; Francis GS
    Heart Fail Clin; 2006 Jul; 2(3):277-90. PubMed ID: 17386897
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of renovascular abnormality in patients undergoing cardiac catheterization.
    Ravichandran R; Rengarajan T; Reddy KN; Rao SM
    J Assoc Physicians India; 2003 Feb; 51():175-7. PubMed ID: 12725262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute coronary syndromes in patients with renal dysfunction.
    Melloni C; Mahaffey KW
    Curr Opin Cardiol; 2008 Jul; 23(4):320-6. PubMed ID: 18520715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population.
    Zhang L; Zuo L; Wang F; Wang M; Wang S; Lv J; Liu L; Wang H
    J Am Soc Nephrol; 2006 Sep; 17(9):2617-21. PubMed ID: 16885404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.